Records of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Chinese Herbal Medicines, published by Elsevier Singapore Pte Ltd, is a distinguished journal dedicated to the exploration and advancement of research in the fields of Complementary and Alternative Medicine and Pharmacology. Since its transition to Open Access in 2020, the journal has significantly broadened its reach, facilitating the dissemination of valuable knowledge to researchers, practitioners, and academics worldwide. With an impressive Q1 ranking in Complementary and Alternative Medicine and a notable Q2 ranking in both Pharmacology categories for 2023, it is recognized for its impactful contributions to the understanding of herbal treatments and their therapeutic applications. Situated in The Netherlands and numerically indexed under ISSN: 1674-6384, the journal aims to provide a platform for innovative studies, analytical reviews, and clinical research that explore the efficacy, safety, and socio-economic factors associated with herbal medicines. The HIndex reflects its growing influence in the scientific community, while Scopus rankings position the journal favorably within its respective fields, making it a vital resource for any serious scholar engaged in herbal medicine studies.

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

The Journal of Herbal Medicine, published by Elsevier GmbH in Germany, stands at the forefront of research in the dynamic and evolving field of complementary and alternative medicine. With an ISSN of 2210-8033 and an E-ISSN of 2210-8041, this journal has been contributing significant insights since its inception in 2011 and continues to be a vital resource through 2024. Recognized for its scholarly rigor, it holds a commendable Q2 ranking in the 2023 Scopus category for Complementary and Alternative Medicine, placing it in the upper echelons of its field with a rank of 32 out of 105 journals, marking it in the 70th percentile. The Journal of Herbal Medicine emphasizes the integration of traditional herbal therapies and modern scientific approaches, offering researchers, professionals, and students a platform for disseminating their findings and fostering an inclusive dialogue on natural medicine's role in healthcare. Although it is not an open-access publication, its commitment to high-quality research makes it an essential read for those wanting to explore the efficacy and application of herbal medicine in contemporary practice.

Avicenna Journal of Phytomedicine, published by Mashhad University of Medical Sciences, is a premier Open Access journal dedicated to advancing the field of phytomedicine. Established in 2011, this journal aims to promote research on the therapeutic potentials of medicinal plants, integrating traditional knowledge with modern pharmacological insights. With an ISSN of 2228-7930 and an E-ISSN of 2228-7949, it has garnered significant attention in the research community, achieving a Q2 ranking in Complementary and Alternative Medicine and a Q3 ranking in Drug Discovery as of 2023. Its Scopus rankings affirm the journal's relevance, with the journal positioned at 37 out of 105 in its category, reflecting a 65th percentile. The Avicenna Journal of Phytomedicine serves as an invaluable resource for researchers, professionals, and students seeking to explore innovative botanical therapies, making it a notable platform for disseminating high-quality research in this burgeoning field.

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.

Jundishapur Journal of Natural Pharmaceutical Products, published by BRIEFLAND in the Netherlands, serves as a pivotal platform for researchers and professionals in the realm of pharmacology and toxicology. With its ISSN 1735-7780 and E-ISSN 2228-7876, the journal has established itself since its inception in 2011, showcasing a commitment to advancing knowledge in natural pharmaceutical products through innovative research. In 2023, it earned a commendable ranking in the Q3 category for Pharmacology, Toxicology, and Pharmaceutics, reflecting its contribution to the field as evidenced by its position in the Scopus rankings. The journal aims to publish high-quality research articles, reviews, and case studies that explore the potential benefits and toxicological aspects of natural products. Although it currently does not offer open access, its rigorous peer-review process ensures that only impactful studies are disseminated, ultimately facilitating a deeper understanding of natural pharmaceutical innovations. For those engaged in this exciting and evolving field, Jundishapur Journal of Natural Pharmaceutical Products is an essential resource that not only expands scholarly discourse but also promotes safe practices in natural product utilization.